Terms: = Leukemia AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Treatment
98 results:
1. Single-cell sequencing unveils T-cell characteristic in acute myeloid leukemia.
Zhu G; Lang W; Fu W; Xu L; Cai J; Zhong H
Int Immunopharmacol; 2024 May; 132():111927. PubMed ID: 38555820
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological features of adult T-cell leukemia/lymphoma with T-follicular helper phenotype.
Muto R; Miyoshi H; Nakashima K; Takeuchi M; Hamasaki M; Ohshima K
Cancer Med; 2024 Mar; 13(6):e7050. PubMed ID: 38506241
[TBL] [Abstract] [Full Text] [Related]
3. Differential co-expression network analysis elucidated genes associated with sensitivity to farnesyltransferase inhibitor and prognosis of acute myeloid leukemia.
Kelesoglu N; Kori M; Yilmaz BK; Duru OA; Arga KY
Cancer Med; 2023 Dec; 12(24):22420-22436. PubMed ID: 38069522
[TBL] [Abstract] [Full Text] [Related]
4. Features of the TCR repertoire associate with patients' clinical and molecular characteristics in acute myeloid leukemia.
Pospiech M; Tamizharasan M; Wei YC; Kumar AMS; Lou M; Milstein J; Alachkar H
Front Immunol; 2023; 14():1236514. PubMed ID: 37928542
[TBL] [Abstract] [Full Text] [Related]
5. Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant models.
Abboud R; Kim S; Staser K; Jayasinghe RG; Lim S; Amatya P; Frye CC; Kopecky B; Ritchey J; Gao F; Lavine K; Kreisel D; DiPersio JF; Choi J
Front Immunol; 2023; 14():1264496. PubMed ID: 37744381
[TBL] [Abstract] [Full Text] [Related]
6. Mocravimod, a S1P receptor modulator, increases T cell counts in bone marrow biopsies from patients undergoing allogeneic hematopoietic stem cell transplantation.
Dertschnig S; Passweg J; Bucher C; Medinger M; Tzankov A
Cell Immunol; 2023 Jul; 388-389():104719. PubMed ID: 37141843
[TBL] [Abstract] [Full Text] [Related]
7. Modeling the interaction between donor-derived regulatory T cells and effector T cells early after allogeneic hematopoietic stem cell transplantation.
Nishiyama N; Ruoff P; Jimenez JC; Miwakeichi F; Nishiyama Y; Yata T
Biosystems; 2023 May; 227-228():104889. PubMed ID: 37019377
[TBL] [Abstract] [Full Text] [Related]
8. Immuno-regulatory malignant B cells contribute to Chronic Lymphocytic leukemia progression.
Mékinian A; Quinquenel A; Belkacem KA; Kanoun F; Dondi E; Franck E; Boubaya M; Mhibik M; Baran-Marszak F; Letestu R; Ajchenbaum-Cymbalista F; Lévy V; Varin-Blank N; Le Roy C
Cancer Gene Ther; 2023 Jul; 30(7):1018-1028. PubMed ID: 36973425
[TBL] [Abstract] [Full Text] [Related]
9. Regulatory T Cell Amelioration of Graft-versus-Host Disease following Allogeneic/Xenogeneic Hematopoietic Stem Cell Transplantation Using Mobilized Mouse and Human Peripheral Blood Donors.
Barreras H; Copsel SN; Bader CS; Ding Y; Wolf D; Cash C; Stacey CJ; Benjamin C; Seavey MM; Wolf J; Jasuja RR; Pfeiffer B; Hill GR; Komanduri KV; Jurecic R; Malek TR; Levy RB
Transplant Cell Ther; 2023 May; 29(5):341.e1-341.e9. PubMed ID: 36804930
[TBL] [Abstract] [Full Text] [Related]
10. Murine allogeneic CAR T cells integrated before or early after posttransplant cyclophosphamide exert antitumor effects.
Patterson MT; Khan SM; Nunes NS; Fletcher RE; Bian J; Hadjis AD; Eckhaus MA; Mendu SK; de Paula Pohl A; Venzon DJ; Choo-Wosoba H; Ishii K; Qin H; Fry TJ; Cam M; Kanakry CG
Blood; 2023 Feb; 141(6):659-672. PubMed ID: 36201744
[TBL] [Abstract] [Full Text] [Related]
11. Early administration of lenalidomide after allogeneic hematopoietic stem cell transplantation suppresses graft-versus-host disease by inhibiting T-cell migration to the gastrointestinal tract.
Tsubokura Y; Yoshimura H; Satake A; Nasa Y; Tsuji R; Ito T; Nomura S
Immun Inflamm Dis; 2022 Sep; 10(9):e688. PubMed ID: 36039651
[TBL] [Abstract] [Full Text] [Related]
12. Paediatric pre-B acute lymphoblastic leukaemia-derived exosomes regulate immune function in human T cells.
Gholipour E; Kahroba H; Soltani N; Samadi P; Sarvarian P; Vakili-Samiani S; Hosein Pour Feizi AA; Soltani-Zangbar MS; Baghersalimi A; Darbandi B; Movassaghpour A; Talebi M; Motavalli R; Mehdizadeh A; Kazemi A; Yousefi M
J Cell Mol Med; 2022 Aug; 26(16):4566-4576. PubMed ID: 35822529
[TBL] [Abstract] [Full Text] [Related]
13. Transient regulatory T-cell targeting triggers immune control of multiple myeloma and prevents disease progression.
Dahlhoff J; Manz H; Steinfatt T; Delgado-Tascon J; Seebacher E; Schneider T; Wilnit A; Mokhtari Z; Tabares P; Böckle D; Rasche L; Martin Kortüm K; Lutz MB; Einsele H; Brandl A; Beilhack A
Leukemia; 2022 Mar; 36(3):790-800. PubMed ID: 34584204
[TBL] [Abstract] [Full Text] [Related]
14. CML derived exosomes promote tumor favorable functional performance in T cells.
Jafarzadeh N; Gholampour MA; Alivand MR; Kavousi S; Arzi L; Rad F; Sadeghizadeh M; Pornour M
BMC Cancer; 2021 Sep; 21(1):1002. PubMed ID: 34493241
[TBL] [Abstract] [Full Text] [Related]
15. Regulatory T Cells in GVHD Therapy.
Guo WW; Su XH; Wang MY; Han MZ; Feng XM; Jiang EL
Front Immunol; 2021; 12():697854. PubMed ID: 34220860
[TBL] [Abstract] [Full Text] [Related]
16. Relative expression and prognostic significance of forkhead box P3 in childhood B-cell acute lymphoblastic leukemia.
Abdelhafeez HEA; Hamid FFA; Hassan NM; Assem MM; Soliman AF
Pediatr Blood Cancer; 2021 Oct; 68(10):e29129. PubMed ID: 34133057
[TBL] [Abstract] [Full Text] [Related]
17. Investigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid leukemia: A Systematic Review.
Wells G; Kennedy PT; Dahal LN
Front Immunol; 2021; 12():651687. PubMed ID: 33777052
[No Abstract] [Full Text] [Related]
18. Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression.
De Paula Pohl A; Schmidt A; Zhang AH; Maldonado T; Königs C; Scott DW
Cell Immunol; 2020 Dec; 358():104222. PubMed ID: 33053469
[TBL] [Abstract] [Full Text] [Related]
19. Repurposing a novel anti-cancer RXR agonist to attenuate murine acute GVHD and maintain graft-versus-leukemia responses.
Thangavelu G; Wang C; Loschi M; Saha A; Osborn MJ; Furlan SN; Aoyama K; McDonald-Hyman C; Aguilar EG; Janesick AS; Chandraratna RA; Refaeli Y; Panoskaltsis-Mortari A; MacDonald KP; Hill GR; Zeiser R; Maillard I; Serody JS; Murphy WJ; Munn DH; Blumberg B; Brown C; Kuchroo V; Kean LS; Hippen KL; Noelle RJ; Blazar BR
Blood; 2021 Feb; 137(8):1090-1103. PubMed ID: 32976550
[TBL] [Abstract] [Full Text] [Related]
20. The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells.
Maharaj K; Powers JJ; Achille A; Mediavilla-Varela M; Gamal W; Burger KL; Fonseca R; Jiang K; Miskin HP; Maryanski D; Monastyrskyi A; Duckett DR; Roush WR; Cleveland JL; Sahakian E; Pinilla-Ibarz J
Blood Adv; 2020 Jul; 4(13):3072-3084. PubMed ID: 32634240
[TBL] [Abstract] [Full Text] [Related]
[Next]
